Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | MMP1 | P03956 | 3/20 | 0.33 |
| ▸ | MMP13 | P45452 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | MMP8 | P22894 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | LOX | P28300 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL7042206 | 0.98 | CA2 (0.35) | CA2ALDH1A1HTTKMT2ALMNA | |
| SCHEMBL8507597 | 0.87 | THRB (0.38) | CA2ALDH1A1HTTKMT2ALMNA | |
| SCHEMBL19844941 | 0.85 | ALDH1A1 (0.37) | CA2ALDH1A1HTTKMT2ALMNA | |
| SCHEMBL10787889 | 0.80 | MMP2 (0.47) | CA2ALDH1A1HTTKMT2ALMNA | |
| SCHEMBL10700258 | 0.80 | LMNA (0.45) | CA2ALDH1A1HTTKMT2ALMNA | |
| Hydrochloric Acid SCHEMBL7923399 | 0.80 | CA2 (0.33) | CA2ALDH1A1HTTKMT2ALMNA | |
| SCHEMBL19844934 | 0.79 | LMNA (0.36) | CA2LMNAMMP1 | |
| SCHEMBL19851311 | 0.78 | — | — | |
| SCHEMBL2685459 | 0.77 | ALDH1A1 (0.60) | ALDH1A1KMT2ALMNAMEN1GAA | |
| SCHEMBL8818862 | 0.77 | CA2 (0.39) | CA2ALDH1A1HTTKMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230058483-A1 | PLANT FIBER BIOCOMPOSITES | NUTECH VENTURES | 2023-02-23 | — | — | US | disclosed |
| US-20180037598-A1 | METHODS OF MAKING AND USING LIGNIN DERIVATIVES | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 2018-02-08 | — | — | US | disclosed |
| WO-2016134162-A1 | METHODS OF MAKING AND USING LIGNIN DERIVATIVES | NUTECH VENTURES (US) | 2016-08-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180037598-A1 | METHODS OF MAKING AND USING LIGNIN DERIVATIVES | HLCS, LOX, DCXR | CA2 4569/4885ALDH1A1 247/4885HTT 4003/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.